Even as Covid vaccine demand rises, firms may take some weeks to up production

Credit: IndiaTimes- Published on April 9, 2021
Indications are that India’s vaccine production is expected to be limited for a few more weeks though a step-up is expected as Serum Institute of India and Bharat Biotech ramp up capacity, some of which is expected to be ready by next month, prompting the government to prioritise vaccinating segments that are seen to be more...

Video credit: KMTV Action 3 News
Published on April 12, 2021 -  03:08
Vaccinations for 12 to 15-year-olds could be available in weeks
Local medical experts believe now that Pfizer has applied for Emergency Use Authorization for their COVID vaccine for those 12-15, that age group could be eligible for a vaccine by the end of the month. Approval will take a few weeks. This, as Douglas County cases soar in those 19 and younger.

You are here

💡 newsR Knowledge: Other News Mentions


Disease caused by severe acute respiratory syndrome coronavirus 2
A further five deaths and 1,979 COVID cases have been reported in the UK in the latest daily figures.
Credit: Sky News - Published 2 hours ago

Prime Minister Narendra Modi on Monday interacted with doctors from across the country and thanked the medical fraternity for the exemplary fight against Covid...
Credit: IndiaTimes - Published 2 hours ago

Bharat Biotech

Indian biotechnology company and vaccine manufacturer
Indigenous Covid-19 vaccine Covaxin has been able to neutralise all key emerging variants, including the double mutant B.1.617 and B.1.1.7, which was first..
Credit: IndiaTimes - Published 1 day ago

Serum Institute of India

Indian biotechnology and pharmaceuticals company
Credit: IndiaTimes - Published 1 week ago

Despite the international pressure and several rounds of negotiations by Serum Institute of India (SII), the government has turned down the request from SII to..
Credit: IndiaTimes - Published 1 week ago

From Rs 250, the cost of vaccines in the private sector has shot up by up to six times. It now ranges from Rs 700-900 for Covishield manufactured by the Serum..
Credit: IndiaTimes - Published 1 week ago

Related videos from verified sources

Moderna CEO Expects FDA Approval 'Weeks Away' For Its COVID Vaccine For Kids 12-To-17 00:22
Credit: WBZ CBS Boston - Published 5 days ago 

‘Will return to India in a few days’: Adar Poonawalla after alleged threat calls 01:50
Credit: HT Digital Content - Published 2 weeks ago 

‘Getting aggressive calls…’: Adar Poonawalla on Covid vaccine pressure in India 01:43
Credit: HT Digital Content - Published 2 weeks ago 

You might like